Precede Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Precede Biosciences's estimated annual revenue is currently $9.5M per year.
- Precede Biosciences's estimated revenue per employee is $155,000
Employee Data
- Precede Biosciences has 61 Employees.
- Precede Biosciences grew their employee count by 61% last year.
Precede Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder and CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Consulting CMO | Reveal Email/Phone |
4 | VP Computational Biology and Bioinformatics | Reveal Email/Phone |
5 | VP, Product Development | Reveal Email/Phone |
6 | VP External Research & Partnerships | Reveal Email/Phone |
7 | Associate Director, Development Operations | Reveal Email/Phone |
8 | Director Laboratory Automation | Reveal Email/Phone |
9 | Associate Director, Corporate Strategy & Operations | Reveal Email/Phone |
10 | Associate Director, Operations & Facilities | Reveal Email/Phone |
Precede Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Precede Biosciences?
We've experienced the significant gaps in our collective ability, as a medical and research community, to access and understand disease-defining biology when it matters most. To address this, we've developed a simple blood test to uncover actionable disease-defining transcriptional biology. Our unique genome-wide platform profiles circulating chromatin and the DNA methylome to deliver resolution into the dynamic activity of individual genes and pathways in diseased tissues from just 1mL of plasma. By partnering with developers of new medicines and advancing our own diagnostic tests, we’re working towards a world where new medicine development efforts succeed more frequently, and where anyone can receive a minimally invasive diagnosis and treatment that’s precise to the biology of their disease.
keywords:N/A
N/A
Total Funding
61
Number of Employees
$9.5M
Revenue (est)
61%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18M | 61 | 24% | N/A |
#2 | $3.5M | 61 | 11% | N/A |
#3 | $8.9M | 61 | 15% | N/A |
#4 | $14.8M | 61 | 7% | N/A |
#5 | $14.8M | 61 | 0% | N/A |